Laboratorios Farmaceuticos Rovi SA is a top pharmaceutical company based in Spain with an ESG score of 15.3, signifying low risk. Specializing in small molecule and specialty biologic drugs, the company markets its diverse product portfolio through a dedicated sales team to hospitals, pharmacies, and specialist physicians in Spain. With a strong focus on research and development, Laboratorios is constantly working on expanding the applications and indications of heparin-derived products. The company's goal is to create new pharmaceutical formulations for regular administration in chronic treatments. Two main segments of the company are Manufacturing and Marketing.